Rgenix Announces $33M Series B Financing

regenix_web1Rgenix, a cancer therapeutics company developing first-in-class drugs targeting novel cancer pathways, announced a $33 million Series B financing led by Novo A/S and Sofinnova Partners, with participation from existing investors including Partnership Fund for New York City, Alexandria Venture Investments, and Conegliano Ventures LP. The financing will support clinical development of Rgenix’s lead drug candidates, RGX-104 and RGX-202, as well as further development of its therapeutics pipeline.

In connection with the financing, Nilesh Kumar of Novo Ventures and Antoine Papiernik of Sofinnova Partners will join the Rgenix Board of Directors together with existing members, including Executive Chairman Eric Rowinsky, M.D., Masoud Tavazoie, M.D. Ph.D., Nancy Chang, Ph.D., and Saeed Tavazoie, Ph.D. Read the full press release about Rgenix’s financing here.

Traverse Biosciences Secures $500k Seed Financing

Traverse Biosciences has announced that it has secured $500,000 in convertible debt financing to support operations and advance product development efforts. The seed financing was led by Excell Partners, with matching funds from a number of individual accredited angel investors. The Research Foundation for the State of New York (RF/SUNY) also participated in the financing, as part of an exclusive license and option agreement executed last year that gave Traverse Biosciences access to the relevant intellectual property for use in animal and human health.

Traverse Biosciences, which began when CEO Joseph Scaduto was serving as a BioEntrepreneur-in-Residence for the Center for Biotechnology, is working to commercialize its proprietary library of Stony Brook University invented chemically-modified curcumins for the treatment of chronic inflammatory conditions and cancers affecting humans and animals.

Read more about Traverse and the recent financing:

 

 

SBIR/STTR Grant Proposal Writing Clinic

SBIR/STTR Grant Proposal Writing Clinic
July 13th and 14th, 8:30am – 4:30am
Small Business Development Center
Stony Brook University R&D Park

The Small Business Development Center (SBDC) at Stony Brook University is holding a free SBIR/STTR Phase I Proposal Writing Clinic July 13, 2016, followed by one-on-one counseling for in process SBIR/STTR proposals on July 14, 2016. Presented and instructed by Sharon Ballard of Enable Ventures, Inc. This clinic will hone your skills and help you to prepare proposals for Phase I or Phase II SBIR/STTR grants.

In order to participate in the clinic you must become a SBDC client. The SBDC will examine your proposed idea to make sure it will qualify for this program. Space in the July clinic is limited. The deadline for submission is June 17, 2016.

In order to start the process please click on the link below to get the proposal application questionnaire:
https://drive.google.com/file/d/0B3Z_tmGrNoJ0Z01XSElZRFNLS3M/view?usp=sharing

Please answer the questions and submit those answers via soft copy to the following email address: sbdc@stonybrook.edu. The submissions will be reviewed by committee. Those selected to participate will be notified after June 17th.

To register or for more information call 631-632-9837 or email sbdc@stonybrook.edu

New York-color with band_400 SBDC

SBU-vert_2clr_rgb_72ppi

Stony Brook Incubator Company Showcase

Join us at the Stony Brook University Incubator Company Showcase at CEWIT on June 2nd ! A joint effort by Stony Brook University’s Centers of Excellence, Centers for Advanced Technology, Business Incubators and Development Centers,  the event showcases one of the nation’s most comprehensive suite of economic development programs and the technological innovations and entrepreneurial advances of the University’s burgeoning community of member companies.

The Incubator Company Showcase will feature over 40 company exhibits and displays. Providing ample time for valuable networking and one-on-one conversations with our scope of biotechnology, energy and information technology companies. The event will also commemorate both the graduation and homegrown success of Codagenix, Inc.

For more information and to register, visit http://goo.gl/5MPWqK.

MIDI Opens New Long Island Headquarters

226-East-Main-Street2MIDI Medical Product Development, recently cut the ribbon new headquarters in a newly constructed Medical Center of Excellence, within Smithtown’s Village of the Branch.
The 15,100 square foot facility is accelerating MIDI’s rapid growth and presence in the medical/healthcare product development industry. The site was chosen based upon its pristine location, professional environment, and proximity to their collaborating partner Stony Brook University Medical Center.

MIDI specializes in meeting FDA regulatory standards for medical devices and provides market research and product engineering and design services for the biotech and medical industries.